HIMS News

Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

Class Action Filing Alert for Hims & Hers Health, Inc. (HIMS): Kahn Swick & Foti, LLC Advises Shareholders With Major Losses to Take Action

Kaplan Fox Announces a Securities Class Action Filed Against Hims & Hers Health, Inc. (NYSE:HIMS) - Lead Plaintiff Deadline is November 2, 2026

HIMS November 2, 2026 Lead Plaintiff Deadline - Robbins LLP Reminds Investors About the Opportunity to Lead the Class Action Lawsuit

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law

Hims & Hers Health (HIMS) Alert: Securities Class Action Pending, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline

The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth

Kaplan Fox Continues to Remind Hims & Hers Health, Inc. (NYSE:HIMS) Investors of the Lead Plaintiff Deadline on November 2, 2026

Pomerantz LLP Reminds Investors: Securities Lawsuit Has Been Filed Against Hims & Hers Health, Inc. – HIMS